Cadisegliatin 800 mg QD Clinical Trials

1 actively recruiting trial across 1 location

Also known as: TTP399

Filter by location:

Scottsdale, Arizona1 trial

Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes

Scottsdale Clinical Trials

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.